Task: Answer the multiple-choice question.
Query: Which drug exhibits a 9.581% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a: CCCCNc1nc(Cl)nc(Nc2ccc(C)cc2)n1
b: COC(=O)CSc1nnc2n1C(C)(C)Cc1ccccc1-2
c: COc1ccc(CN2CCN(CCC(C)C)C(CCO)C2)cc1Cn1cccn1
Answer: a. CCCCNc1nc(Cl)nc(Nc2ccc(C)cc2)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCCNc1nc(Cl)nc(Nc2ccc(C)cc2)n1
CCCCNc1nc(Cl)nc(Nc2ccc(C)cc2)n1
4-N-butyl-6-chloro-2-N-(4-methylphenyl)-1,3,5-triazine-2,4-diamine